You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,162,802


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,162,802
Title: Synergistic combination therapy using benazepril and amlodipine for the treatment of cardiovascular disorders and compositions therefor
Abstract:A method for the treatment of a variety of cardiovascular disorders and related conditions in a mammal having at least one such disorder or condition is disclosed comprising treating the mammal with cotherapy comprising benazepril and amlodipine or pharmaceutically acceptable salts of either or both. Combination formulations of benazepril and amlodipine for use in the method are also disclosed.
Inventor(s): Papa; Joseph (Allschwil, CH), Henis; Marc M. J. (Randolph, NJ)
Assignee:
Application Number:07/848,816
Patent Claim Types:
see list of patent claims
Use; Dosage form; Formulation; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 6,162,802: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for navigating the complex landscape of intellectual property. This article will delve into the specifics of United States Patent 6,162,802, exploring its claims, scope, and the broader patent landscape it inhabits.

Background of the Patent

United States Patent 6,162,802, titled "Pharmaceutical Compositions of Amlodipine and Benazepril," was granted to Novartis Pharmaceuticals Corporation. This patent pertains to a combination of two active pharmaceutical ingredients: amlodipine, a calcium channel blocker, and benazepril, an angiotensin-converting enzyme (ACE) inhibitor. These drugs are commonly used together to treat hypertension and other cardiovascular conditions.

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the scope of the invention. Here are some key aspects:

  • Claim 1: This claim describes a pharmaceutical composition comprising a combination of amlodipine and benazepril in specific ratios, along with excipients and other formulation components. It specifies the therapeutic use of this combination for treating hypertension and other cardiovascular diseases[5].

  • Claim 2: This claim details the method of manufacturing the pharmaceutical composition, including the steps involved in mixing, granulating, and compressing the active ingredients and excipients into a tablet form.

  • Claim 3: This claim covers the use of the pharmaceutical composition for the treatment of specific medical conditions, such as hypertension, angina, and heart failure.

Dependent Claims

Dependent claims further narrow down the scope of the independent claims by adding additional limitations or specifications. For example:

  • Claim 4: This claim specifies the dosage forms of the pharmaceutical composition, such as tablets or capsules.
  • Claim 5: This claim details the specific ratios of amlodipine to benazepril in the composition.

Scope of the Patent

The scope of the patent is defined by the claims and the description provided in the patent specification. Here are some key points:

Therapeutic Use

The patent covers the use of the combination of amlodipine and benazepril for treating various cardiovascular conditions. This includes hypertension, angina, and heart failure, among others.

Formulation

The patent describes specific formulations of the combination, including the ratios of the active ingredients and the types of excipients used. This ensures that the patented composition has a unique profile that distinguishes it from other similar products.

Manufacturing Process

The patent also covers the method of manufacturing the pharmaceutical composition, which includes detailed steps for mixing, granulating, and compressing the ingredients into a final dosage form.

Patent Landscape

Related Patents

To understand the broader patent landscape, it is essential to identify related patents and patent families. Tools like the USPTO's Patent Public Search and the Global Dossier can be used to find related applications and patents filed in other jurisdictions[1].

Competitor Patents

Competitors in the pharmaceutical industry may have filed similar patents or have pending applications that could impact the scope of this patent. Analyzing these patents using patent analytics tools can help identify gaps and opportunities in the intellectual property portfolio[3].

Expiration and Generic Challenges

The patent's expiration date is critical for understanding when generic versions of the drug can be introduced. For U.S. Patent 6,162,802, the expiration date would have allowed generic manufacturers to seek approval after the patent's term ended. For instance, Teva Pharmaceutical Industries Ltd. announced tentative approval for a generic version of a similar combination product upon the expiry of a related patent[5].

Patent Analytics and Claim Coverage

Claim Coverage Matrix

Using a Claim Coverage Matrix, as described by patent analytics services, can help in understanding which patents and claims are actively protecting the intellectual property related to this combination drug. This matrix categorizes patents by claims and scope concepts, making it easier to identify gaps in coverage and future design opportunities[3].

Interactive Claim Charts

Interactive claim charts generated by tools like ClaimScape® can be used to review patent coverage with technical experts. These charts help in determining whether a particular scope concept is applicable to a target product or method, highlighting areas where claim coverage is lacking[3].

Legal and Regulatory Considerations

Opposition and Appeals

Patents can face opposition and appeals, as seen in the case of European patent disputes. Understanding the legal and regulatory framework is crucial for navigating these challenges. For example, the European Patent Office's opposition division and appeal processes can significantly impact the validity and scope of a patent[2].

Global Patent System

The global patent system, facilitated by tools like the Global Dossier, allows for the integration of patent information across different jurisdictions. This helps in managing the patent family and understanding the broader international landscape[1].

Key Takeaways

  • Claims and Scope: The patent's claims define the specific combination of amlodipine and benazepril, the formulation, and the therapeutic use.
  • Patent Landscape: Understanding related patents, competitor patents, and the expiration dates is crucial for strategic planning.
  • Patent Analytics: Tools like Claim Coverage Matrix and interactive claim charts are essential for managing and analyzing the patent portfolio.
  • Legal and Regulatory: Navigating oppositions, appeals, and the global patent system is vital for maintaining and enforcing patent rights.

FAQs

Q: What is the primary use of the combination drug described in U.S. Patent 6,162,802?

A: The primary use is for treating hypertension and other cardiovascular conditions.

Q: How can one identify related patents and patent families?

A: Using tools like the USPTO's Patent Public Search and the Global Dossier can help in identifying related patents and patent families.

Q: What is the significance of a Claim Coverage Matrix in patent analytics?

A: A Claim Coverage Matrix helps in categorizing patents by claims and scope concepts, making it easier to identify gaps in coverage and future design opportunities.

Q: How do interactive claim charts assist in patent analysis?

A: Interactive claim charts help technical experts determine whether a particular scope concept is applicable to a target product or method, highlighting areas where claim coverage is lacking.

Q: What happens when a patent expires?

A: When a patent expires, generic manufacturers can seek approval to produce and market generic versions of the drug.

Sources

  1. USPTO: "Search for patents - USPTO"
  2. EPO: "BESCHWERDEKAMMERN DES EUROPÄISCHEN PATENTAMTS"
  3. SLWIP: "Patent Analytics | Intellectual Property Law"
  4. NCSES: "Invention: U.S. and Comparative Global Trends"
  5. Teva Pharmaceutical Industries Ltd.: "Teva Announces Tentative Approval of Generic Lotrel"

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,162,802

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.